Candida dubliniensis: An emerging pathogen

Clinical Microbiology Newsletter

Volumn 23, Issue 11, 2001, Pages 83-86

  Kiehn, Timothy E ^a   Sebti, Abdelghani ^a   Sepkowitz, Kent A ^a   Wong, May ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC SENSITIVITY; CANDIDA DUBLINIENSIS; CLINICAL FEATURE; EPIDEMIOLOGICAL DATA; GENOTYPE; HUMAN; LABORATORY DIAGNOSIS; PHENOTYPE; PREVALENCE; REVIEW; VIRULENCE;

EID: 0035369281     PISSN: 01964399     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-4399(01)89030-9     Document Type: Article

References (24)

1. Candida dubliniensis sp. nov.: Phenotypic and molecular characterization of a novel species associated with oral candidisis in HIV-infected individuals
2. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals
3. Candida dubliniensis: Characteristics and identification
4. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation
5. Candida dubliniensis fungemia: The first four cases in North America
6. Candida dubliniensis at a cancer center
7. Prevalence of Candida dubliniensis isolates in a yeast stock collection
8. Identification of Candida dubliniensis in a prospective study of patients in the United States
9. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals
10. Candidiasis: The emergence of a novel species, Candida dubliniensis
11. Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus
12. Coaggregation of Candida dubliniensis with Fusobacterium nucleatum
13. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans
14. Rapid identification of Candida dubliniensis with commercial yeast identification systems
15. Identification of Candida dubliniensis based on temperature and utilization of xylose and alphamethyl-D-glucoside as determined with the API 20C AUX and Vitek YBC systems
16. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates
17. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences
18. Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans
19. Rapid identification of Candida dubliniensis using a species-specific molecular beacon
20. Molecular beacons: Probes that fluoresce upon hybridization
21. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro
22. Identification and expression of multidrug transporters responsible for fluconazole resistance in Candida dubliniensis
23. Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS
24. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents